Literature DB >> 11402502

A novel anti-CD18 mAb recognizes an activation-related epitope and induces a high-affinity conformation in leukocyte integrins.

K Drbal1, P Angelisová, J Cerný, I Hilgert, V Horejsí.   

Abstract

Monoclonal antibody MEM-148 was previously shown to recognize CD18 chains in a free form unassociated within leukocyte integrin heterodimers, but yet it is paradoxically able to induce a high-affinity conformation in the native, cell surface expressed LFA-1 molecules. Our results based on kinetics of binding, immunoprecipitation and cell-aggregation experiments demonstrate that the mAb does bind to and stabilizes a specific conformation of LFA-1 heterodimers apparently distinguished by an increased affinity to its cellular ligand(s). A similar high-affinity conformation of LFA-1, in which the MEM-148 epitope becomes exposed, is induced also by a Mg2+/EDTA or low pH (5.5-6.5) treatments which may mimic physiologically relevant situations in normal or inflamed tissues. Thus, mAb MEM-148 is a novel valuable tool for detection and induction of specific conformations of human leukocyte integrins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402502     DOI: 10.1016/S0171-2985(01)80017-6

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

1.  Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2.

Authors:  Xing Chen; Can Xie; Noritaka Nishida; Zongli Li; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

2.  Regulation of integrin affinity on cell surfaces.

Authors:  Thomas Schürpf; Timothy A Springer
Journal:  EMBO J       Date:  2011-09-23       Impact factor: 11.598

3.  Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1.

Authors:  Koichi Yuki; Weiming Bu; Jin Xi; Mehmet Sen; Motomu Shimaoka; Roderic G Eckenhoff
Journal:  FASEB J       Date:  2012-07-19       Impact factor: 5.191

4.  Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier.

Authors:  Slava Rom; Viviana Zuluaga-Ramirez; Holly Dykstra; Nancy L Reichenbach; Pal Pacher; Yuri Persidsky
Journal:  Am J Pathol       Date:  2013-09-18       Impact factor: 4.307

5.  Forcing switch from short- to intermediate- and long-lived states of the alphaA domain generates LFA-1/ICAM-1 catch bonds.

Authors:  Wei Chen; Jizhong Lou; Cheng Zhu
Journal:  J Biol Chem       Date:  2010-09-06       Impact factor: 5.157

6.  Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.

Authors:  Ana Laura Fazio; Wesley Kendle; Kimson Hoang; Erica Korleski; Isabelle Lemasson; Nicholas Polakowski
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

8.  TLR signaling paralyzes monocyte chemotaxis through synergized effects of p38 MAPK and global Rap-1 activation.

Authors:  Ling Yi; Prabha Chandrasekaran; Sundararajan Venkatesan
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

9.  Detection of Diffusion Heterogeneity in Single Particle Tracking Trajectories Using a Hidden Markov Model with Measurement Noise Propagation.

Authors:  Paddy J Slator; Christopher W Cairo; Nigel J Burroughs
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

10.  Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation.

Authors:  Slava Rom; Viviana Zuluaga-Ramirez; Nancy L Reichenbach; Michelle A Erickson; Malika Winfield; Sachin Gajghate; Melpo Christofidou-Solomidou; Kelly L Jordan-Sciutto; Yuri Persidsky
Journal:  J Neuroinflammation       Date:  2018-01-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.